Home » Topics » Regulatory » EMA

EMA
RSS

European CHMP hands down positive opinions for Xyrem and Prevenar

Jan. 30, 2007

Sprycel approved in E.U.

Dec. 1, 2006

Microdosing/phase 0 trials: Paradigm shift aims to speed new drug development, improve efficiency

Nov. 7, 2006

Aldara recommended for approval for actinic keratosis in Europe

Oct. 23, 2006

Positive opinion handed down in Europe for new Glivec indication

Oct. 23, 2006

Europe's CHMP recommends Hycamtin for new indication

Oct. 23, 2006

Tandemact recommended for approval in E.U.

Oct. 23, 2006

European CHMP issues positive opinion on Diacomit submission

Oct. 23, 2006

Adrovance recommended for approval in E.U.

Oct. 23, 2006

Novo Nordisk withdraws E.U. application to expand repaglinide product labels

Oct. 18, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...